Ann Cohen insider trades
Open-market stock purchases and sales by Ann Cohen, Director at Niagen Bioscience, Inc, from SEC Form 4 filings since Apr 15, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 24, 2026 | NAGE Niagen Bioscience, Inc | Bought (not open market) | — |